Allen Biotechnology Co ABC Tesamorelin
As of 9 Aug 2026, Finnrick has published 9 independent lab tests of Tesamorelin from Allen Biotechnology Co ABC: 7 passed and 2 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 4 Jun 2026. The current Finnrick rating for Allen Biotechnology Co ABC Tesamorelin is 58%.
Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.
Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.
| Date | Result | Certificate |
|---|---|---|
| 4 Jun 2026 | Pass | Certificate ac6a53t |
| 12 Mar 2026 | Pass | Certificate xnr55et |
| 2 Mar 2026 | Pass | Certificate jt9tdc5 |
| 1 Mar 2026 | Pass | Certificate 48g7t47 |
| 25 Feb 2026 | Pass | Certificate 7btm4ra |
| 19 Feb 2026 | Fail | Certificate m6kt8kj |
| 11 Feb 2026 | Pass | Certificate bynjqma |
| 4 Feb 2026 | Pass | Certificate e4vb8gc |
| 25 Nov 2025 | Fail | Certificate 7zwdj26 |